Chapman, K., Pavord, I., Paggiaro, P., Sciurba, F., Bafadhel, M., Bradford, E., . . . Yancey, S. (2018). Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Thoracic Society.
Чикаго стиль цитування (17-те видання)Chapman, K., et al. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Thoracic Society, 2018.
Стиль цитування MLA (9-ме видання)Chapman, K., et al. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Thoracic Society, 2018.